A significantly higher percentage of CD3+CD8+PD-1+ cells were found in tumour tissue compared with TDLNs (median 18.2 (range 7.41–46.49) vs. 5.52 (range 0.75–13.65), p < 0.05). This evidence concerns the gene CD8A and neoplasm.